These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37005902)

  • 1. Botulinum toxin type A outcomes in infants with refractory congenital muscular torticollis.
    Sinn CN; Rinaldi RJ; McLaughlin MJ
    J Pediatr Rehabil Med; 2023; 16(3):539-552. PubMed ID: 37005902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type a in the treatment of children with congenital muscular torticollis.
    Oleszek JL; Chang N; Apkon SD; Wilson PE
    Am J Phys Med Rehabil; 2005 Oct; 84(10):813-6. PubMed ID: 16205437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recalcitrant idiopathic muscular torticollis in infants with botulinum toxin type a.
    Joyce MB; de Chalain TM
    J Craniofac Surg; 2005 Mar; 16(2):321-7. PubMed ID: 15750434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Custom neck orthosis in combination with onabotulinumtoxinA for the treatment of refractory congenital muscular torticollis: A case report.
    Sytsma TT; Terman RW; Brandenburg JE
    J Pediatr Rehabil Med; 2016 May; 9(2):155-8. PubMed ID: 27285808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effectiveness and Safety of Botulinum Toxin Injections for the Treatment of Congenital Muscular Torticollis.
    Qiu X; Cui Z; Tang G; Deng H; Xiong Z; Han S; Tang S
    J Craniofac Surg; 2020; 31(8):2160-2166. PubMed ID: 33136847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Combined Botulinum Toxin and Physical Therapy for Treatment Resistant Congenital Muscular Torticollis.
    Limpaphayom N; Kohan E; Huser A; Michalska-Flynn M; Stewart S; Dobbs MB
    J Pediatr Orthop; 2019; 39(5):e343-e348. PubMed ID: 30451814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis.
    Peng-Chen Z; Thompson A; Rodriguez RL
    Neurologist; 2016 Mar; 21(2):30-1. PubMed ID: 26926853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A relieves sternocleidomastoid muscle fibrosis in congenital muscular torticollis.
    Jiang B; Zu W; Xu J; Xiong Z; Zhang Y; Gao S; Ge S; Zhang L
    Int J Biol Macromol; 2018 Jun; 112():1014-1020. PubMed ID: 29447964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.
    Collins A; Jankovic J
    Neurology; 2006 Sep; 67(6):1083-5. PubMed ID: 17000985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of botulinum toxin type A in the management of neonatal brachial plexus palsy.
    Michaud LJ; Louden EJ; Lippert WC; Allgier AJ; Foad SL; Mehlman CT
    PM R; 2014 Dec; 6(12):1107-19. PubMed ID: 24798262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA.
    Hefter H; Samadzadeh S; Moll M
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33121133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between sonography of sternocleidomastoid muscle and cervical passive range of motion in infants with congenital muscular torticollis.
    Lin CH; Hsu HC; Hou YJ; Chen KH; Lai SH; Chang WM
    Biomed J; 2018 Dec; 41(6):369-375. PubMed ID: 30709579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
    Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.
    Ferreira JJ; Colosimo C; Bhidayasiri R; Marti MJ; Maisonobe P; Om S
    Parkinsonism Relat Disord; 2015 Feb; 21(2):111-5. PubMed ID: 25499753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital Muscular Torticollis-Current Understanding and Perinatal Risk Factors: A Retrospective Analysis.
    Płomiński J; Olesińska J; Kamelska-Sadowska AM; Nowakowski JJ; Zaborowska-Sapeta K
    Healthcare (Basel); 2023 Dec; 12(1):. PubMed ID: 38200919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.